Oscar Hevia
Coral Gables, FLNPI 1609994508
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,486 of the $13,816 with a category attached, or 90.4%. 3 manufacturers reported payments, led by AbbVie at 52.4% of the total.
Across 34 payments — averaging $406.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Galderma Laboratories, L.p.$7K
- Musculoskeletal Transplant Foundation Inc.$9
Across 150 payments — averaging $6348.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$850K
- Galderma Laboratories, L.p.$102K
- E.r. Squibb & Sons, L.L.C.$61
What the payments were for
- Consulting fees$12,48690%
- Travel & lodging$6445%
- Food & beverage$6865%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $7,236 |
| Galderma Laboratories, L.p. | 3 | $6,572 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$5,063
- BOTOX$1,655
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.